U.S. healthcare wastes millions of dollars treating costly endoscopes (some costing $50,000-$60,000), and other advanced medical instruments, as disposable assets rather than managing them appropriately. These costs, often hidden in capital accounts and over-priced service contracts and repairs, could be better spent on patient care and medical equipment. This situation, exacerbated by the lack of transparency and regulation in the instrument repair industry, demands a revised approach to instrument ownership within the healthcare sector.
The True Cost of Focusing on Cost Instead of Cost-Effectiveness
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is
